title: Leptin regulation of proangiogenic molecules in benign and cancerous endometrial cells.
abstract: Several proangiogenic/proinflammatory factors involved in endometrial cancer are regulated by leptin, but the signaling mechanisms responsible for these leptin-induced actions are largely unknown. Here, we report that in benign (primary and HES) and cancerous-endometrial epithelial cells (EEC) (An3Ca, SK-UT2 and Ishikawa), leptin in a dose-dependent manner regulates vascular endothelial growth factor, (VEGF); interleukin-1 beta, (IL-1beta); leukemia inhibitory factor, (LIF) and their respective receptors, VEGFR2, IL-1R tI and LIFR. Remarkably, leptin induces a greater increase in VEGF/VEGFR2 and LIF levels in cancer than in benign cells. However, IL-1beta was only increased by leptin in benign primary-EEC. Cancer-EEC expressed higher levels of leptin receptor (full-length OB-Rb and short isoforms) in contrast to benign primary-EEC. Leptin-mediated activation of JAK2 (janus kinase 2) was upstream to the activation of PI-3K (phosphatidylinositol-3 kinase) and/or MAPK (mitogen-activated protein kinase) signaling pathways. Leptin induction of cytokines/receptors generally involved JAK2 and MAPK activation, but PI-3K phosphorylation was required for leptin increase of LIF, IL-1/IL-1R tI. Leptin-mediated activation of mTOR (mammalian target of Rapamycin), mainly linked to MAPK, played a central role in leptin regulation of all cytokines and receptors. These results suggest that leptin's effects are cell-specific and could confer a proliferative or cell survival advantage or possibly promote endometrial thickness. Leptin's effects on proangiogenic molecules were more evident in malignant versus benign cells and may imply that there is an underlying shift in leptin-induced cell signaling pathways in endometrial cancer cells.
authors.affiliation: Boston Biomedical Research Institute (BBRI), Watertown, MA, USA.
authors.forename: Cecilia
authors.initials: C
authors.lastname: Carino
authors.forename: Alexander B
authors.initials: AB
authors.lastname: Olawaiye
authors.forename: Salandre
authors.initials: S
authors.lastname: Cherfils
authors.forename: Takehiro
authors.initials: T
authors.lastname: Serikawa
authors.forename: Maureen P
authors.initials: MP
authors.lastname: Lynch
authors.forename: Bo R
authors.initials: BR
authors.lastname: Rueda
authors.forename: Ruben R
authors.initials: RR
authors.lastname: Gonzalez
mesh_terms: D000230:Adenocarcinoma / Q000098:blood supply / Q000378:metabolism*; D015153:Blotting, Western; D016889:Endometrial Neoplasms / Q000098:blood supply / Q000378:metabolism*; D004717:Endometrium / Q000098:blood supply / Q000378:metabolism*; D005260:Female; D006801:Humans; D053583:Interleukin-1beta / Q000378:metabolism; D020738:Leptin / Q000378:metabolism*; D053605:Leukemia Inhibitory Factor / Q000378:metabolism; D009389:Neovascularization, Pathologic / Q000378:metabolism*; D011494:Protein Kinases / Q000378:metabolism*; D017472:Receptors, Interleukin-1 / Q000378:metabolism; D053606:Receptors, OSM-LIF / Q000378:metabolism; D015398:Signal Transduction; D058570:TOR Serine-Threonine Kinases; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000378:metabolism
chemical_list: D053583:Interleukin-1beta; C507837:LIF protein, human; D020738:Leptin; D053605:Leukemia Inhibitory Factor; D017472:Receptors, Interleukin-1; D053606:Receptors, OSM-LIF; D042461:Vascular Endothelial Growth Factor A; D011494:Protein Kinases; C546842:MTOR protein, human; D040301:Vascular Endothelial Growth Factor Receptor-2; D058570:TOR Serine-Threonine Kinases
references.citation: Cancer Res. 2005 Sep 1;65(17):7800-8
references.pmid: 16140948
references.citation: Nat Med. 1995 Nov;1(11):1155-61
references.pmid: 7584987
references.citation: FASEB J. 2002 Sep;16(11):1471-3
references.pmid: 12205052
references.citation: J Cell Physiol. 2006 Apr;207(1):12-22
references.pmid: 16110483
references.citation: Blood. 2006 Dec 15;108(13):4156-62
references.pmid: 16912221
references.citation: Biochem Biophys Res Commun. 2003 Jun 20;306(1):139-43
references.pmid: 12788079
references.citation: J Surg Res. 2004 Feb;116(2):337-49
references.pmid: 15013374
references.citation: J Biol Chem. 2004 Jan 23;279(4):2737-46
references.pmid: 14576155
references.citation: J Biol Chem. 1997 Mar 7;272(10):6093-6
references.pmid: 9102398
references.citation: Int J Mol Med. 2003 Jul;12(1):95-8
references.pmid: 12792816
references.citation: Endocrine. 2001 Oct;16(1):21-8
references.pmid: 11822823
references.citation: J Biol Chem. 1997 Aug 8;272(32):19982-6
references.pmid: 9242667
references.citation: Hum Reprod. 1999 Oct;14(10):2485-92
references.pmid: 10527974
references.citation: J Clin Endocrinol Metab. 2000 May;85(5):1946-50
references.pmid: 10843179
references.citation: Biochim Biophys Acta. 2002 Oct 21;1592(2):107-16
references.pmid: 12379472
references.citation: J Neurosci. 2001 Apr 1;21(7):2413-24
references.pmid: 11264315
references.citation: Science. 1997 Sep 12;277(5332):1630-5
references.pmid: 9287210
references.citation: Lancet. 2004 Nov 13-19;364(9447):1789-99
references.pmid: 15541453
references.citation: Gynecol Oncol. 1991 Aug;42(2):161-4
references.pmid: 1832651
references.citation: J Biol Chem. 1998 Aug 21;273(34):22128-35
references.pmid: 9705358
references.citation: Anal Biochem. 1976 May 7;72:248-54
references.pmid: 942051
references.citation: J Biol Chem. 1997 Jun 27;272(26):16216-23
references.pmid: 9195922
references.citation: Endocrinology. 2008 Feb;149(2):506-14
references.pmid: 17962343
references.citation: Cancer Lett. 2006 Jul 8;238(1):61-8
references.pmid: 16085355
references.citation: Biochem J. 2006 Jan 1;393(Pt 1):7-20
references.pmid: 16336196
references.citation: Nature. 1995 Oct 19;377(6550):591-4
references.pmid: 7566171
references.citation: Exp Mol Med. 2001 Jun 30;33(2):95-102
references.pmid: 11460888
references.citation: Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8374-8
references.pmid: 8710878
references.citation: Nature. 2002 Jan 17;415(6869):339-43
references.pmid: 11797013
references.citation: Eur J Obstet Gynecol Reprod Biol. 2005 Jan 10;118(1):101-8
references.pmid: 15596282
references.citation: Nat Rev Immunol. 2004 May;4(5):371-9
references.pmid: 15122202
references.citation: Endocr Relat Cancer. 2006 Jun;13(2):629-40
references.pmid: 16728588
references.citation: Int J Gynecol Cancer. 2001 Jan-Feb;11(1):54-60
references.pmid: 11285034
references.citation: Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6155-9
references.pmid: 8327496
references.citation: Arthritis Rheum. 2002 Oct;46(10):2604-12
references.pmid: 12384918
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2840-7
references.pmid: 16364998
references.citation: Hum Reprod Update. 2000 May-Jun;6(3):290-300
references.pmid: 10874574
references.citation: Mol Hum Reprod. 2002 May;8(5):456-64
references.pmid: 11994543
references.citation: Endocr Rev. 1997 Feb;18(1):4-25
references.pmid: 9034784
references.citation: Arterioscler Thromb Vasc Biol. 1999 Aug;19(8):1835-42
references.pmid: 10446061
references.citation: Endocrinology. 2004 Aug;145(8):3850-7
references.pmid: 15142989
references.citation: Circ Res. 1998 Nov 16;83(10):1059-66
references.pmid: 9815153
references.citation: Fertil Steril. 2003 Sep;80 Suppl 2:783-7
references.pmid: 14505754
references.citation: Ann Nutr Metab. 2002;46(3-4):147-51
references.pmid: 12169858
references.citation: Biochem Biophys Res Commun. 1997 Feb 3;231(1):26-9
references.pmid: 9070213
references.citation: J Mol Neurosci. 2007;32(1):80-9
references.pmid: 17873291
references.citation: J Biol Chem. 2001 Feb 16;276(7):4747-55
references.pmid: 11085989
references.citation: J Clin Endocrinol Metab. 2000 Dec;85(12):4883-8
references.pmid: 11134157
references.citation: Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6231-5
references.pmid: 8692797
references.citation: J Biol Chem. 2003 Oct 24;278(43):42660-7
references.pmid: 12902351
references.citation: Cell Signal. 2002 Aug;14(8):655-63
references.pmid: 12020765
references.citation: Ann N Y Acad Sci. 2007 Jan;1095:90-8
references.pmid: 17404022
references.citation: Gynecol Oncol. 2004 Mar;92(3):769-75
references.pmid: 14984939
references.citation: J Biol Chem. 1997 May 16;272(20):12897-900
references.pmid: 9148892
references.citation: Annu Rev Immunol. 2000;18:143-64
references.pmid: 10837055
references.citation: Diabetologia. 1997 Nov;40(11):1358-62
references.pmid: 9389430
references.citation: FEBS J. 2005 Jan;272(1):109-19
references.pmid: 15634336
references.citation: Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):698-702
references.pmid: 1370585
references.citation: J Biol Chem. 2002 Nov 1;277(44):41547-55
references.pmid: 12196522
references.citation: Endocrinology. 2005 Feb;146(2):694-701
references.pmid: 15539553
references.citation: Mol Hum Reprod. 2000 Jul;6(7):595-601
references.pmid: 10871646
references.citation: Reproduction. 2005 Aug;130(2):131-45
references.pmid: 16049151
references.citation: Endocrine. 2003 Jul;21(2):185-95
references.pmid: 12897384
references.citation: Mol Hum Reprod. 2003 Jul;9(7):395-8
references.pmid: 12802046
references.citation: J Cell Sci. 2000 Dec;113 Pt 23:4331-9
references.pmid: 11069777
references.citation: J Clin Endocrinol Metab. 2000 Jul;85(7):2483-7
references.pmid: 10902797
references.citation: Cell. 2005 Apr 22;121(2):179-93
references.pmid: 15851026
references.citation: J Biol Chem. 2006 Sep 8;281(36):26320-8
references.pmid: 16825198
references.citation: Mol Hum Reprod. 2003 Mar;9(3):151-8
references.pmid: 12606591